Venla Olsson
Postdoctoral Researcher
A.I. Virtanen Institute for Molecular Sciences, Faculty of Health Sciences
venla.olsson@uef.fi
Research groups
Publications
11/11 items-
Redox Properties and in Vivo Magnetic Resonance Imaging of Cyclodextrin-Polynitroxides Contrast Agents
Franco, Lorenzo; Isse, Abdirisak Ahmed; Barbon, Antonio; Altomare, Lina; Hyppönen, Viivi; Rosa, Jessica; Olsson, Venla; Kettunen, Mikko; Melone, Lucio. 2023. Chemphyschem. 24: -
Gene therapy and immunotherapy for malignant glioma: development of novel therapies in rat models of brain cancer
Olsson, Venla. 2022. Publications of the University of Eastern Finland. Dissertations in Health Sciences -
Lentivirus vector-mediated genetic manipulation of oncogenic pathways induces tumor formation in rabbit brain
Ahmad, Farizan; Hyvärinen, Anna; Pirinen, Agnieszka; Olsson, Venla; Rummukainen, Jaana; Immonen, Arto; Närväinen, Johanna; Tuunanen, Pasi; Liimatainen, Timo; Kärkkäinen, Virve; Koistinaho, Jari; Ylä-Herttuala, Seppo. 2021. Molecular medicine reports. 23: 422 -
Cyclodextrin-based organic radical contrast agents for in vivo imaging of glioma
Melone, Lucio; Bach, Alice; Lamura, Gianrico; Canepa, Fabio; Nivajärvi, Riikka; Olsson, Venla; Kettunen, Mikko. 2020. ChemPlusChem. 85: 1171-1178 -
Detection of lentiviral suicide gene therapy in C6 rat glioma using hyperpolarised [1-13 C]pyruvate
Nivajärvi, R; Olsson, V; Hyppönen, V; Bowen, S; Leinonen, HM; Lesch, HP; Ardenkjaer-Larsen, JH; Gröhn, OHJ; Ylä-Herttuala, S; Kettunen, MI. 2020. Nmr in biomedicine. 33: e4250 -
Pahanlaatuisen gliooman hoidon tulevaisuuden näkymiä
Olsson, Venla; Niittykoski, Minna; Stedt, Hanna; Virsunen, Heli; Ylä-Herttuala, Seppo. 2020. Duodecim. 136: 1242-1248 -
Assessment of the Relaxation-Enhancing Properties of a Nitroxide-Based Contrast Agent TEEPO-Glc with In Vivo Magnetic Resonance Imaging
Soikkeli, Maiju; Kettunen, Mikko I; Nivajärvi, Riikka; Olsson, Venla; Rönkkö, Seppo; Laakkonen, Johanna P; Lehto, Vesa-Pekka; Kavakka, Jari; Heikkinen, Sami. 2019. Contrast media and molecular imaging. 2019: 5629597 -
Preclinical proof-of-concept, analytical development and commercial scale production of lentiviral vector in adherent cells
Leinonen, HM; Lipponen, EM; Valkama, AJ; Hynynen, H; Oruetxebarria, I; Turkki, V; Olsson, V; Kurkipuro, J; Samaranayake, H; Määttä, A-M; Parker, NR; Ylä-Herttuala, S; Lesch, HP. 2019. Molecular therapy. Methods & clinical development. 15: 63-71 -
Human Vascular Endothelial Growth Factor A165 Expression Induces the Mouse Model of Neovascular Age-Related Macular Degeneration
Kokki, Emmi; Karttunen, Tommi; Olsson, Venla; Kinnunen, Kati; Ylä-Herttuala, Seppo. 2018. Genes. 9: E438 -
Up-regulation of Mismatch Repair Pathway by Suicide Gene Therapy: Implications on the use of Temozolomide Treatment in Malignant Glioma
Samaranayake, Haritha Dhammika; Olsson, Venla; Kurkipuro, Jere Tuomas; Määttä, Ann-Marie; Stedt, Hanna; Kärkkäinen, Hanna-Riikka; Kaikkonen, Minna U; Taavitsainen, Miia; Vuorio, Taina; Parker, Nigel; Ylä-Herttuala, Seppo. 2018. Journal of cancer science & therapy. 10: 214-222